Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Kedudukan dalam Saham #11659
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Harga Saham
$8.92
Disegerakkan terakhir: 2024-10-18
Modal Pasaran
$674.03M
Perubahan (1 hari)
-5.14%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan Jeisys Medical Inc. (287410)

Kategori

Pendapatan untuk Jeisys Medical Inc. (287410)
Pendapatan pada Jun 2024 TTM: $27.72M
Menurut laporan kewangan terkini Jeisys Medical Inc., pendapatan semasa syarikat ialah $27.72M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $26.85M, peningkatan berbanding pendapatan pada tahun 2021 yang berjumlah $11.01M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Jeisys Medical Inc. dari 2020 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $27.72M 1.10%
2023 $27.42M 2.12%
2022 $26.85M 143.83%
2021 $11.01M 45.55%
2020 $7.57M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.51B 26,993.21%
US
$5.15B 18,469.54%
US
$5.56B 19,966.50%
IE
$3.86B 13,827.16%
US
- -
DE